Every Form 4 that Omnicell Inc (OMCL) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow OMCL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OMCL filings page.
OMNICELL, INC. (OMCL) reported that officer Brian H. Nutt, VP and Chief Accounting Officer, had 937 shares of common stock withheld on 2026-08-15 at $37.30 per share to cover taxes due on the vesting of restricted stock units. Following this tax-withholding disposition, his direct holdings total 22,265.8924 shares of common stock. The reported balance also reflects 343.2789 shares purchased the same day under Omnicell’s Employee Stock Purchase Plan.
OMNICELL, INC. (OMCL) reported insider activity by President & COO Njoku Nnamdi. On August 17, 2026, he sold 3,083 shares of common stock at $36.85 per share in an open-market transaction effected under a Rule 10b5-1 trading plan adopted on February 9, 2026. On August 15, 2026, 3,670 shares were disposed of at $37.30 per share to cover taxes due upon vesting of restricted stock units, with the reported balance adjusted for 882.119 shares purchased under the company’s Employee Stock Purchase Plan.
OMNICELL, INC. (OMCL) Chairman and CEO Randall A. Lipps reported an automatic withholding of 12,350 shares of Common Stock at $37.30 on August 15, 2026 to cover taxes due upon vesting of restricted stock units. After this tax-withholding disposition and inclusion of 261.6432 shares purchased the same day under the Employee Stock Purchase Plan, he holds 511,095.7173 shares directly. He also reports indirect holdings of 345,861 shares in a trust with his wife and 8,051 shares in a trust for his children.
OMNICELL, INC. (OMCL) reported an insider transaction by executive vice president and chief legal/administrative officer Corey J. Manley. On 2026-08-15, 4,025 shares of common stock were withheld to pay taxes due upon vesting of restricted stock units at a reference price of $37.30 per share. After this tax-withholding disposition and a same-date purchase of 226.4621 shares under the Employee Stock Purchase Plan, Manley directly held 108,984.8013 shares of Omnicell common stock.
Randall A. Lipps, chairman and CEO of Omnicell, Inc., reported an indirect sale of 10,000 shares of common stock on July 15, 2026 at $47.00 per share, executed pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
After this transaction, a trust with his wife holds 345,861 shares indirectly, a separate trust for his children holds 8,051 shares indirectly, and he holds 523,184.0741 shares directly.
Njoku Nnamdi reported acquisition or exercise transactions in this Form 4 filing.
OMNICELL, INC. President & COO Nnamdi Njoku received an equity award of 12,309 shares of common stock in the form of Restricted Stock Units (RSUs). These RSUs were granted under the company’s equity incentive plan in connection with his promotion effective July 1, 2026.
Following this award, Njoku holds a total of 167,094.4457 shares of common stock directly. One-third of the RSUs will vest on the first anniversary of the grant date, with the remaining two-thirds vesting in equal installments on the second and third anniversaries, tying the award to multi‑year service.
Omnicell, Inc. director Eileen J. Voynick received a grant of 4,785 shares of common stock as restricted shares for her services on the Board of Directors under the company’s equity incentive plan. The award carries no cash exercise price and will vest in full on the one-year anniversary of the grant date. Following this grant, she directly holds 20,011 shares of Omnicell common stock.
Seim Robin Gene reported acquisition or exercise transactions in this Form 4 filing.
Omnicell director Robin Gene Seim received a grant of 4,845 shares of common stock as equity compensation. The shares are restricted and were awarded under Omnicell's equity incentive plan for service on the Board of Directors.
These restricted shares will vest in full on the one-year anniversary of the grant date. Following this award, Seim directly holds a total of 52,198 shares of Omnicell common stock.
Bousa Edward Peter reported acquisition or exercise transactions in this Form 4 filing.
Omnicell, Inc. director Edward Peter Bousa received a grant of 4,603 shares of Common Stock as restricted shares under the company’s equity incentive plan. The award was given as consideration for his services as a Board member and will vest in full on the one-year anniversary of the grant date.
After this grant, Bousa directly holds a total of 22,589 shares of Omnicell common stock.
Scott Bruce E reported acquisition or exercise transactions in this Form 4 filing.
OMNICELL, INC. director Scott E. Bruce received a grant of 4,627 shares of Common Stock as equity compensation for his service on the board. The grant was made at no cash cost to him and was issued under the company’s equity incentive plan. Following this award, he directly holds 27,600 shares. The restricted shares are scheduled to vest in full on the one-year anniversary of the grant date, tying his compensation to the company’s longer-term performance.
PARRISH MARK W reported acquisition or exercise transactions in this Form 4 filing.
Director Mark W. Parrish of OMNICELL, INC. received a grant of 4,845 shares of common stock on June 1, 2026. The shares were awarded at $0.00 per share under the company’s equity incentive plan as compensation for his service on the Board.
These are restricted shares that will vest in full on the one-year anniversary of the grant date, meaning Parrish must remain in his board role for a year to receive them outright. After this grant, he holds 70,100 common shares directly. This is a compensation-related award, not an open-market stock purchase.
Bauer Joanne B reported acquisition or exercise transactions in this Form 4 filing.
Omnicell director Joanne B. Bauer received a grant of 5,027 shares of common stock as equity compensation for her service on the Board of Directors. The restricted shares were granted at no cash cost per share and are scheduled to vest in full on the one-year anniversary of the grant date. Following this award, Bauer directly holds 49,922 shares of Omnicell common stock.
Ghoshal Kaushik reported acquisition or exercise transactions in this Form 4 filing.
OMNICELL, INC. director Kaushik Ghoshal received a grant of restricted common stock as equity compensation for Board service. The grant covers 4,603 shares at no purchase price under the company’s equity incentive plan and Board of Directors Compensation Plan, bringing his direct holdings to 19,123 shares.
The restricted shares are scheduled to vest in full on the one-year anniversary of the June 1, 2026 grant date. This is a compensation-related award, not an open-market stock purchase or sale, and therefore does not reflect a discretionary trading decision in the company’s shares.
Garrett Mary reported acquisition or exercise transactions in this Form 4 filing.
Omnicell director Mary Garrett received a grant of 5,027 shares of common stock as compensation for Board service under the company’s equity incentive and Board compensation plans. The restricted shares were awarded at no cash cost and will vest in full on the one-year anniversary of the grant date, bringing her direct holdings to 22,202 shares.
Omnicell EVP and COO Nnamdi Njoku reported an open-market sale of 3,090 shares of common stock at $43.22 per share. In a separate transaction, 3,660 shares were withheld to cover taxes upon vesting of restricted stock units. After these transactions, he directly holds about 154,785 shares. The sale was executed under a pre-arranged Rule 10b5-1 trading plan.
Omnicell, Inc. VP and Chief Accounting Officer Brian H. Nutt reported a routine tax-related share disposition. On this Form 4, 226 shares of common stock were withheld at $43.12 per share to cover taxes due upon vesting of restricted stock units. After this withholding, he directly holds 22,859.6135 shares, and there was no open-market buy or sell transaction.
OMNICELL, INC. executive Corey J. Manley, EVP and Chief Legal/Admin Officer, reported two transactions in company common stock. He sold 5,025 shares in an open-market trade at an exact price of $43.22 per share pursuant to a pre-arranged Rule 10b5-1 trading plan. Separately, 4,041 shares were withheld to cover taxes due on vesting of restricted stock units. After these transactions, he directly holds about 112,783 common shares.
OMNICELL, INC. Chairman, President and CEO Randall A. Lipps reported a tax-related share disposition. On May 15, 2026, 12,347 shares of common stock were withheld at $43.12 per share to cover taxes due upon the vesting of restricted stock units.
After this withholding, he directly holds about 523,184.0741 shares of Omnicell common stock. He also reports indirect holdings of 8,051 shares in a trust for his children and 355,861 shares in a trust with his wife.
Njoku Nnamdi reported acquisition or exercise transactions in this Form 4 filing.
OMNICELL, INC. Executive Vice President and Chief Operating Officer Nnamdi Njoku received a grant of 46,296 shares of common stock in the form of Restricted Stock Units as equity compensation. The award was granted under the company’s equity incentive plan at no cash cost to him.
One-third of these RSUs will vest on the first anniversary of the April 1, 2026 grant date. The remaining two-thirds will vest in equal installments on the second and third anniversaries. After this grant, Njoku directly holds 161,535.4457 shares of Omnicell common stock.
Manley Corey J reported acquisition or exercise transactions in this Form 4 filing.
OMNICELL, INC. executive Corey J. Manley, EVP & Chief Legal/Admin Officer, received a grant of 25,132 Restricted Stock Units (RSUs) of common stock at a stated price of $0.00 per share, reflecting a compensation-related equity award rather than a market purchase.
According to the award terms, one-third of the RSUs will vest on the first anniversary of the grant date, with the remaining two-thirds vesting in equal installments on the second and third anniversaries. Following this grant, Manley directly holds a total of 121,849.3392 shares of Omnicell common stock, including this new RSU award.
LIPPS RANDALL A reported acquisition or exercise transactions in this Form 4 filing.
OMNICELL, INC. Chairman, President and CEO Randall A. Lipps received a grant of 90,939 shares of Common Stock in the form of restricted stock units at a price of $0.00 per share on 2026-04-01. These RSUs were granted under the company’s equity incentive plan.
According to the vesting schedule, one-third of the RSUs will vest on the first anniversary of the grant date, with the remaining two-thirds vesting in equal installments on the second and third anniversaries. After this grant, Lipps directly holds 535,531.0741 shares of Common Stock.
In addition to his direct holdings, shares are also held indirectly in trusts: 355,861 shares are held in trust with his wife, and 8,051 shares are held in trust for the benefit of his children.
Radford Harlan Baird reported acquisition or exercise transactions in this Form 4 filing.
OMNICELL, INC. reported that EVP & Chief Financial Officer Harlan Baird Radford received a grant of 37,037 shares of Common Stock in the form of Restricted Stock Units under the company’s equity incentive plan. One-third of the RSUs will vest on the first anniversary of the grant date, with the remaining two-thirds vesting in equal installments on the second and third anniversaries. Following this award, Radford directly holds 69,969 shares of Common Stock.
NUTT BRIAN H. reported acquisition or exercise transactions in this Form 4 filing.
OMNICELL, INC. reported that VP and Chief Accounting Officer Brian H. Nutt received a grant of 5,556 shares of common stock in the form of Restricted Stock Units under the company’s equity incentive plan. These RSUs were awarded at no cash cost per share and increase his directly held position to 23,085.6135 shares.
According to the award terms, one-third of the RSUs will vest on the first anniversary of the grant date, and the remaining two-thirds will vest in equal installments on the second and third anniversaries. This structure is typical for long-term incentive compensation designed to retain executives over multiple years.
Omnicell, Inc. Chairman, President and CEO Randall A. Lipps reported vesting of 79,494 performance-based restricted stock units of Common Stock. These RSUs were originally granted on March 15, 2025 and became earned after the company met stock performance objectives versus the S&P 1000 Healthcare Index, with 25% vesting on the one-year anniversary of the grant.
In connection with this vesting, 15,642 shares were withheld at $34.40 per share to cover tax liabilities, leaving 444,592 Common Stock shares held directly after the transactions. Separate from his direct holdings, 355,861 shares are held in a trust with his wife and 8,051 shares are held in a trust for his children.
Omnicell EVP and COO Nnamdi Njoku reported equity compensation changes tied to performance-based restricted stock units. He acquired 37,409 common shares at no cost upon vesting of previously granted performance-based RSUs after the company met stock performance objectives versus the S&P 1000 Healthcare Index.
Of these vested shares, 8,456 were withheld to cover taxes at a price of $34.40 per share. Following these transactions, Njoku directly holds 115,239.4457 shares of Omnicell common stock. The remaining performance-based RSUs will vest in equal quarterly installments over three years.
Omnicell EVP and Chief Legal/Admin Officer Corey J. Manley reported equity compensation vesting and related share transactions. On March 15, 2026, he acquired 22,445 shares of Common Stock at $0.00 per share as a grant tied to performance-based restricted stock units previously awarded on March 15, 2025.
On the same date, 3,819 shares were withheld at $34.40 per share to cover taxes due upon vesting of these restricted stock units. On March 16, 2026, he sold 7,405 shares in an open-market transaction at an exact price of $34.69 per share under a pre-arranged Rule 10b5-1 trading plan adopted on June 13, 2025.
Following these transactions, Manley directly held 96,717.3392 shares of Omnicell Common Stock. The remaining performance-based restricted stock units from the March 2025 grant will vest in equal quarterly increments every three months over a three-year period, on each May 15, August 15, November 15, and February 15.
Omnicell VP and Chief Accounting Officer Brian H. Nutt reported routine equity transactions involving company common stock. On February 15, 2026, 258 shares were disposed of to cover tax withholding tied to vesting restricted stock units. The reported balance also reflects 445.6135 shares purchased that day under Omnicell's Employee Stock Purchase Plan, bringing his direct holdings to 17,529.6135 shares.
Omnicell EVP and COO Nnamdi Njoku reported a tax-related share disposition. On February 15, 2026, 1,146 shares of Omnicell common stock were withheld at $36.50 per share to cover taxes due on vesting restricted stock units, rather than being sold in the open market.
After this withholding and an additional 239.4457 shares purchased under the company’s Employee Stock Purchase Plan on February 15, 2026, Njoku’s direct holdings total 86,286.4457 shares of Omnicell common stock.
Omnicell, Inc. executive Corey J. Manley reported share dispositions. He sold 4,243 shares of common stock in an open-market transaction at an exact price of $36.59 per share under a Rule 10b5-1 trading plan adopted on June 13, 2025.
Separately, 2,022 shares were withheld to cover taxes due on the vesting of restricted stock units, which is a tax-withholding disposition rather than an open-market sale. After these transactions and the purchase of 87.3392 shares under the Employee Stock Purchase Plan on February 15, 2026, he directly owned 85,496.3392 shares.
OMNICELL, INC. Chairman, President and CEO Randall A. Lipps reported a tax-withholding disposition of 5,294 shares of common stock on February 15, 2026. The shares were withheld at a price of $36.50 per share to cover taxes due on vesting restricted stock units.
After this transaction, Mr. Lipps directly owned 380,740.0741 shares of Omnicell common stock. He also reported indirect holdings of 355,861 shares held in trust with his wife and 8,051 shares held in trust for the benefit of his children.
Omnicell executive Corey J. Manley, EVP & Chief Legal/Admin Officer, sold 6,106 shares of Omnicell common stock on January 8, 2026. The sale was executed at an exact price of $49.90 per share under a pre-arranged Rule 10b5-1 trading plan adopted on June 13, 2025, which is designed to allow insiders to sell stock according to preset instructions. After this transaction, Manley beneficially owned 91,674 shares of Omnicell common stock directly.
Omnicell, Inc.'s Executive Vice President and Chief Legal/Administrative Officer reported routine share movements. On December 15, 2025, 224 shares of common stock were withheld to cover taxes due on the vesting of restricted stock units. On December 16, 2025, the executive sold 278 shares of Omnicell common stock at an exact price of $43.30 per share.
The filing notes that the sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on June 13, 2025, which is designed to allow insiders to sell shares according to a preset schedule. After these transactions, the executive beneficially owned 97,780 shares of Omnicell common stock, all held directly.
Omnicell, Inc. reported an insider equity transaction by its Chairman, President and CEO and director, Randall Lipps. On 12/15/2025, the company withheld 1,147 shares of common stock at $43.27 per share to cover taxes due upon the vesting of restricted stock units, which is a non-open-market transaction. After this tax withholding, Mr. Lipps beneficially owned 385,501 shares of Omnicell common stock directly, plus 355,861 shares held in a trust with his wife and 8,051 shares held in trust for the benefit of his children.
Omnicell, Inc. (OMCL) executive Brian H. Nutt, the VP and Chief Accounting Officer, reported a small insider transaction on Form 4. The filing shows that 226 shares of common stock were withheld to cover taxes due in connection with the vesting of restricted stock units at a price of $35.12 per share. After this tax withholding, Nutt directly owns 17,342 shares of Omnicell common stock. This is an administrative equity event tied to compensation rather than an open‑market buy or sell.
Omnicell, Inc. reported an insider share disposition by its Chairman, President and CEO, Randall A. Lipps. On 11/15/2025, Lipps disposed of 8,437 shares of Omnicell common stock at a price of $35.12 per share, coded as an "F" transaction, which indicates shares were withheld to cover taxes related to vesting restricted stock units. Following this transaction, he directly owned 386,648 shares. He also held 355,861 shares in a trust with his wife and 8,051 shares in a trust for the benefit of his children.
Omnicell, Inc. executive reports routine share withholding for taxes. The company’s EVP and Chief Operating Officer reported the disposition of 4,095 shares of Omnicell common stock on 11/15/2025 at a price of $35.12 per share, coded as an "F" transaction, which indicates shares were withheld to cover taxes due on vesting of restricted stock units.
After this tax withholding, the executive beneficially owns 87,193 shares of Omnicell common stock. This balance includes an adjustment for 359 shares purchased under Omnicell’s Employee Stock Purchase Plan on 8/15/2025, as noted in the footnotes.
Omnicell, Inc. (OMCL) reported an equity award to its Executive Vice President & Chief Financial Officer, H. Baird Radford III, on a Form 4. On 11/15/2025, he received 32,932 shares of Omnicell common stock in the form of restricted stock units granted under the company’s equity incentive plan at a stated price of $0 per share, reflecting a stock-based award rather than a cash purchase. After this grant, he beneficially owns 32,932 shares directly. The award vests over time: 25% of the shares are scheduled to vest on November 15, 2026, and the remaining 75% vest in equal quarterly installments over three years on 2/15, 5/15, 8/15, and 11/15, aligning his compensation with longer-term company performance.
Omnicell, Inc. (OMCL) reported an insider equity transaction involving an executive advisor. On 11/15/2025, 7,368 shares of common stock were withheld at a price of $35.12 per share to cover taxes due on the vesting of restricted stock units. After this tax withholding, the reporting person beneficially owned 117,808 shares of Omnicell common stock directly. The filing notes that the transaction may have been executed under a Rule 10b5-1 trading plan.
Omnicell, Inc. executive reports routine stock transactions. The EVP and Chief Legal/Administrative Officer reported two transactions in Omnicell common stock. On 11/15/2025, 2,792 shares were withheld to cover taxes due on vesting of restricted stock units at a price of $35.12 per share, leaving 107,861 shares beneficially owned. On 11/17/2025, the executive sold 3,473 shares at an exact price of $34.90 per share under a pre-arranged Rule 10b5-1 trading plan adopted on June 13, 2025, resulting in 104,388 shares beneficially owned after the sale. The filing is made by one reporting person.